High blood pressure Circulatory System Essential (primary) hypertension
Conditions
Interventions
Method of randomisation
Randomisation will be stratified by the practitioner conducting the baseline consultation, using the method of random permuted blocks. Patient allocation ratio
Sponsors
University of Cambridge
Cambridgeshire and Peterborough CCG
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Practitioners (practice nurses, health care assistants): Practitioners will be included if they advise patients with hypertension during annual reviews, medication reviews, blood pressure checks or similar consultations; at least one practitioner will be recruited per practice Patients (patients with high blood pressure): Patients will be included if they: 1. Have a diagnosis of HBP, or comorbidities of HBP type 2 diabetes cholesterol 2. Are prescribed at least one antihypertensive medication for at least six months before study recruitment, as confirmed by practice records 3. Have poorly controlled HBP, as indicated by clinical measures 4. Have a good understanding of English 5. Are able to use mobile phones 6. Have the capacity to provide informed consent
Exclusion criteria
Exclusion criteria: Patients will be excluded if they: 1. Have blood pressure > 200/100mm Hg, postural HBP (>20 mmHg systolic drop) 2. Have a diagnosis of dementia, aphasia or other cognitive difficulties that could affect study participation 3. Have had a recent severe life-threatening event or are under treatment for another long-term health condition (e.g. cancer) 4. Receive kidney dialysis 5. Take part in another study 6. Plan to move from the area in the next 6 months 7. BP not managed by their GP practice
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Recruitment rate recorded as the number of eligible participants who consent to participate in the study for 3 months. 2. Attrition rate recorded as the number of participants who consent to participate that remain in the study and complete the follow up measurements at 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Fidelity and engagement with the online CRF measured as the duration and number of activities completed during the baseline consultation 2. Fidelity and engagement with the text message or app measured as the number and consent of text message and app notifications received, interactions, and interaction time intervals during the 3 months intervention 3. Medication adherence measured using the 5-item Medication Adherence Report Scale, two single items, the 8-item Morisky questionnaire, Cumulative Medication Gap and urine analysis at baseline and follow up 4. Systolic blood pressure measured using blood pressure monitors at baseline and follow up 5. Lipoprotein and glycaemic control measured using blood samples at baseline and follow up | — |
Countries
United Kingdom
Contacts
Public ContactKaterina Kassavou
Outcome results
None listed